Brain & pineal
One of 5 mechanistic pathways to 🧬 Organ-specific bioregulation · 9 options
The pineal peptides carry the program's boldest claims — circadian restoration and telomerase activation. They are also the ones people have the most subjective experience with, which cuts both ways.
The pineal claims are about circadian restoration, and the cortisol curve is the readable half of that. If the rhythm doesn't move, nothing did.
Cortisol (AM)Vitamin D (25-Hydroxy)hs-CRP (High-Sensitivity C-Reactive Protein)Homocysteine😴 Sleep Quality & Recovery covers these in one panel →
What engages this pathway
Ordered by how directly each one acts on the mechanism above — never by how much trial evidence exists. Each links to its full breakdown with dosing, half-life and vendor.
💉 Epitalon
The pineal tetrapeptide (Ala-Glu-Asp-Gly). Reported to restore melatonin rhythm and activate telomerase in cell culture. The most widely used peptide in this class and the one with the largest gap between reputation and independent evidence.
💉 Pinealon
A brain-and-pineal tripeptide proposed to be neuroprotective under hypoxic and oxidative stress.
💉 Visoluten
The retinal peptide, which belongs in this grouping rather than beside it: the retina is CNS tissue by embryology, an outgrowth of the diencephalon, and it is also the light input the pineal peptides above depend on. Proposed for age-related decline in visual function; retinal structure is imaged routinely, which makes the absence of published imaging the notable part.
💉 Cerebramin
The brain CYTAMIN — the oral extract line, 155mg per tablet. No study of it has ever been published. The one measured number in this whole family belongs to the injectable Cortexin, which reached mouse brain at 6-8% of whole-blood concentration and screened as a glutamatergic agent rather than as a DNA-binding regulator. An oral extract has to clear the gut before it meets that same barrier.
💉 Epiphamin
The pineal CYTAMIN, and at $101 for 40 tablets the most expensive item on that shelf against $42 for most of the line. The single PubMed record naming it is a 2002 hypothesis paper on aspirin-sensitive asthma that proposes the pineal extracts as an approach; no trial followed. Every human melatonin result in this family belongs to the injectable Epithalamin. Dim-light melatonin onset before and after a course is the measurement nobody has taken.
💉 Cerluten
Brain and central nervous system bioregulator.
💉 Cortagen
Cerebral cortex peptide, studied in the program for peripheral nerve and cognitive recovery.
💉 Cerebrolysin
Again not Khavinson — a porcine brain peptide preparation with genuine European trial data in stroke and dementia. The comparison is instructive.
💉 Retinalamin
The injectable retinal extract that all of Visoluten's borrowed literature actually belongs to — same tissue, same school, given by injection rather than swallowed, and the member of this family with the largest human record. It is also NOT tretinoin, which is what an automated catalog match called it. Read the negative first: 36 rabbits, photochemical retinal damage, and its own country's ophthalmology journal reported no significant functional or morphological evidence of neuroprotection.
What actually decides this outcome, in order of size
Two claims are made for the pineal peptides and they are not equally supported, equally safe or equally checkable. Ranked by how much of the outcome each one owns:
- THE TELOMERASE CLAIM, which is the reason this pathway gets attention and is double-edged by construction. Epitalon has been reported to increase telomere length in human cell lines through telomerase upregulation, and that paper carries a published correction in the record Al-Dulaimi 2025 Al-Dulaimi 2025. Read both. Then note what the capability is: sustained telomerase activity is one of the things a cell needs in order to divide without limit, which is why it is a cancer-biology topic as much as a longevity one. The commercial framing takes only the upside of a capability whose downside is in the same sentence.
- The rhythm claim, which is more modest and better matched to the evidence. Pineal peptides were reported to normalize the daily melatonin rhythm in older people and old monkeys Korkushko 2007 Goncharova 2003, and a later preparation was reported to increase pineal melatonin synthesis in elderly people Trofimova 2017. That is a restoration argument in an aged population, which is a narrower and more defensible claim than the one on the packaging.
- What the molecule is, which is unusually well defined here. Epitalon is a tetrapeptide with a known formula and mass National Center for Biotechnology Information, and its effect on gene expression and protein synthesis during neurogenesis has been described Khavinson 2020. Chemical definition is a genuine advantage this pathway has over the organ-concentrate shelf, and it should not be confused with clinical evidence.
- Which species and which preparation the data came from. The long-running work is rodent Anisimov 2003 and primate Goncharova 2003; chromatin-level effects were reported in cultured cells Lezhava 2007; recent work is in vitro retinal wound healing Gatta 2025 and post-ovulatory oocyte aging in mice Yue 2022. There is no randomized human outcome trial in the set, and the honest statement of the position is exactly that.
- Whether an oral or injected short peptide reaches the tissue in question, which nothing here establishes. Immune cell differentiation in the pineal has been studied Linkova 2011, but the step from an administered tetrapeptide to a concentration at a central target is assumed rather than measured. That is the same unstated assumption as on Thymus & immune and it is worth naming twice.
- Whether the comparator category has fared better, because it has been tested more. A telomerase activator marketed as a natural product has both a maintenance-program report Harley 2011 and a randomized human telomere-length trial Salvador 2016. That is a more developed evidence path for the same claim, and it is the right benchmark to hold these against.
The order to run these in, and what has to be true first
Read the correction notice before the claim, decide which of the two claims you are actually buying, and put the cheap objective measurements in place first — because the subjective experience on this pathway is unusually strong and unusually uninformative.
- Baseline bloods before any course. Complete Blood Count (CBC) with Differential, Comprehensive Metabolic Panel (CMP), hs-CRP (High-Sensitivity C-Reactive Protein) and a morning Cortisol (AM) with the draw time written down. None of these measures a pineal effect; all of them catch the things that make somebody feel different during a twenty-day course.
- Epitalon is the defined tetrapeptide and the item the literature is actually about National Center for Biotechnology Information Khavinson 2020. If anything here is going to be tried, this is the one with a molecular identity and a published cell-line result, correction and all Al-Dulaimi 2025 Al-Dulaimi 2025.
- Pinealon is the tripeptide sibling and is sold for cognitive rather than rhythmic claims. It shares the program's framing and has less specific published material behind it than epitalon does.
- Epiphamin and Cerebramin are the organ-concentrate versions of the same idea. Standardized peptide content from animal tissue, taken orally, with the injectable-to-oral gap unaddressed. The rhythm literature they lean on was generated with different preparations Korkushko 2007 Trofimova 2017.
- Cerluten, Visoluten and Cortagen are tissue-directed concentrates for other organs entirely, filed on this page because they belong to the same program rather than because they act on the pineal. Match the product to the tissue you actually care about.
- Cerebrolysin is the outlier and is a different class of thing. It is a porcine brain-derived peptide preparation given parenterally, with its own mechanistic literature Wu 2021. Grouping it with oral organ concentrates understates how different its administration and its evidence base are.
- If the goal is sleep timing rather than aging, buy the timing intervention. Circadian & melatonergic rhythm covers what actually moves a clock, and it is cheaper and better characterized than anything on this page.
- If the goal is telomere biology specifically, read the comparator first. The randomized human trial of a natural-product telomerase activator Salvador 2016 and its earlier program report Harley 2011 are the closest thing to a human answer that exists for this claim, and they are about a different molecule.
What gets bought for this that cannot move it
The category that fails structurally is the oral organ concentrate bought for a central nervous system effect. The pineal sits behind a blood-brain barrier, the preparations are peptide mixtures taken by mouth, and no published human pharmacokinetic work establishes that an intact peptide from a capsule reaches central tissue at a concentration that could do what the cell and animal work describes Khavinson 2020 Linkova 2011. That is an extrapolation, it is labeled as one, and it applies to every organ concentrate on this page.
The direction failure is the telomerase claim itself. Upregulating telomerase is presented as unambiguously good. The same capability is one of the enabling features of a cell that has escaped replicative limits, which is why telomerase is studied in oncology at least as much as in gerontology. The published cell-line report is explicit about the mechanism it proposes and carries a correction Al-Dulaimi 2025 Al-Dulaimi 2025; the chromatin work is in cultured cells Lezhava 2007. None of that demonstrates harm in humans. It does mean the claim cannot honestly be sold as one-directional, and a page that lists it as a pure benefit has chosen a side of an open question.
The evidence failure is subtler than 'it is all Russian'. The supporting studies are real, specific and mostly mechanistic: gene expression Khavinson 2020, retinal wound healing in vitro Gatta 2025, oocyte aging in mice Yue 2022, rodent lifespan Anisimov 2003. Each is informative about a mechanism. None is a human outcome, and stacking twelve mechanism papers does not add up to one clinical result — which is exactly why the comparator's randomized human trial Salvador 2016 is worth more than the whole stack for answering the question a buyer is asking.
If the goal underneath is different, so is the page. If it is sleep timing, Circadian & melatonergic rhythm. If it is thymic and immune, Thymus & immune. If it is cognition with a mechanism, BDNF & neurotrophic signaling. If it is mortality data rather than mechanism, The unglamorous evidence — what actually has mortality data is the page that answers with trials. And anybody with a current or past cancer diagnosis should treat a telomerase-activation claim as a conversation with an oncologist rather than a purchase.
How you would know it was working, on a real read-out and a real timescale
This page makes two predictions. Nothing here will change a marker a reader can buy that reflects the claimed mechanism, because telomere length assays are noisy and pineal output is not routinely measurable; and a morning Cortisol (AM) with a recorded draw time will say more about whether a rhythm shifted than any subjective report of a twenty-day course will.
- A morning Cortisol (AM) within an hour of waking, same clock time, at baseline and 12 weeks. The rhythm claim is the more defensible of the two Korkushko 2007 Trofimova 2017, and the cortisol awakening pattern is the cheapest routinely available window on diurnal organization. The draw time is the measurement; without it the result is uninterpretable.
- Complete Blood Count (CBC) with Differential and Comprehensive Metabolic Panel (CMP) at baseline and 12 weeks. These are unlicensed preparations, often injected, often cycled for years. Blood count and liver and renal chemistry are the minimum safety net and they are cheap.
- hs-CRP (High-Sensitivity C-Reactive Protein) at baseline and 12 weeks, as falsification. If a peptide course is producing a systemic effect, this is where it would appear; a flat line is the expected and reassuring result.
- IGF-1 (Insulin-like Growth Factor 1) at baseline and 12 weeks if the reason for buying is a general anti-aging claim. It is the one growth-axis number that is routinely available, and it belongs here as a check that nothing is moving a growth axis unintentionally.
- Sleep timing written down nightly for the four weeks around any course. Free, and it tests the specific published claim Korkushko 2007 rather than the marketing one.
What will fool you. Commercial telomere-length testing has substantial measurement variability, so a change between two consumer reports is not evidence of an intervention effect — which matters because that is exactly the test people buy after reading the cell-line paper Al-Dulaimi 2025. A correction notice attached to a paper is part of that paper's record Al-Dulaimi 2025. In vitro and rodent results Gatta 2025 Yue 2022 Anisimov 2003 describe mechanisms rather than doses. Courses are typically ten to twenty days, which is short enough for any coincident change to be attributed to them. And Cerebrolysin is parenteral and a different class Wu 2021, so its literature does not transfer to an oral capsule beside it on the shelf.
Sources read for these sections
- Al-Dulaimi S. Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Biogerontology 2025 · PMID 40908429
- Al-Dulaimi S. Correction: Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Biogerontology 2025 · PMID 41240216
- Khavinson V. AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism. Molecules 2020 · PMID 32019204
- Anisimov VN, Khavinson VKh, Popovich IG, Zabezhinski MA, Alimova IN, Rosenfeld SV, Zavarzina NY, Semenchenko AV, Yashin AI. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology 2003;4(4):193–202
- Korkushko OV. Normalizing effect of the pineal gland peptides on the daily melatonin rhythm in old monkeys and elderly people. Advances in Gerontology 2007 [Russian] · PMID 17969590
- Goncharova ND. Peptide correction of age-related pineal disturbances in monkeys. Advances in Gerontology 2003 [Russian] · PMID 14743609
- Lezhava T, Jokhadze T. Activation of pericentromeric and telomeric heterochromatin in cultured lymphocytes from old individuals. Annals of the New York Academy of Sciences 2007 · PMID 17460203
- Harley CB, et al. A natural product telomerase activator as part of a health maintenance program. Rejuvenation Research 2011 · PMID 20822369
- Salvador L, et al. A Natural Product Telomerase Activator Lengthens Telomeres in Humans: A Randomized, Double Blind, and Placebo Controlled Study. Rejuvenation Research 2016 · PMID 26950204
- Gatta M. The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy. Stem Cell Reviews and Reports 2025 · PMID 40493162
- Yue X. Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro. Aging (Albany NY) 2022 · PMID 35413689
- National Center for Biotechnology Information. PubChem Compound Summary CID 219042 — Epitalon (C14H22N4O9, 390.35 g/mol). PubChem, NCBI
- Linkova NS. Peptidegic stimulation of differentiation of pineal immune cells. Bulletin of Experimental Biology and Medicine 2011 · PMID 22803057
- Wu X, Liu Y, Zhu L, Wang Y, Ren Y, Cheng B, Ren L, Ge K, Li H. Cerebroprotein Hydrolysate-I Inhibits Hippocampal Neuronal Apoptosis by Activating PI3K/Akt Signaling Pathway in Vascular Dementia Mice. Neuropsychiatric Disease and Treatment 2021;17:2359-2368 · PMID 34305399
- Trofimova SV. Pineamin increased pineal melatonin synthesis in elderly people. Advances in Gerontology 2017 [Russian] · PMID 28849889
The other 4 routes to organ-specific bioregulation
Pick the pathway that matches where you are actually stuck. An appetite drug does nothing for someone who already undereats.
You know the goal. Skool has the plan.
This pathway is one arm of The Organ-specific bioregulation Blueprint. The members' version has where this arm sits in the sequence, what to stack it with, and the markers that tell you to keep going or stop.
Open The Organ-specific bioregulation Blueprint in Skool →$10/mo, cancel anytime.
← Open this pathway in the interactive Vault
Frequently asked questions
The pineal peptides carry the program's boldest claims — circadian restoration and telomerase activation. They are also the ones people have the most subjective experience with, which cuts both ways.
9 options are mapped to this pathway in the Vault, including Epitalon, Pinealon, Visoluten, Cerebramin. They are grouped by the mechanism they act through rather than ranked by how much trial evidence exists — 1 carry clinical validation and 8 are mechanistic predictions.
The pineal claims are about circadian restoration, and the cortisol curve is the readable half of that. If the rhythm doesn't move, nothing did. The markers worth checking are Cortisol (AM), Vitamin D (25-Hydroxy), hs-CRP (High-Sensitivity C-Reactive Protein), Homocysteine.
Unproven is not the same as ineffective. Of the 9 options on this pathway, 1 have clinical validation and 8 are graded theoretical — meaning the mechanism is sound but the specific human trial has not been run, which is true of a great deal of what works in this space. Nothing on this page is ordered by evidence tier, because sorting by trial count would bury the compounds you came looking for.
Where this goes next
Everything above is the free case for Brain & pineal. The protocol — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.